Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00762931 · ClinicalTrials.gov registry record · NA

Neurostimulation for the Relief of Acute Bronchoconstriction

A NA study of Asthma, sponsored by ElectroCore.

Completed
Registry status
NA
Development phase
25
Enrollment target
6
Study locations

NCT00762931 is a NA study of Asthma that has completed, run by ElectroCore. The registered enrollment target is 25 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (98% lower). The trial reports 6 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00762931, a NA study of Asthma, has completed, sponsored by ElectroCore.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target
6
Study locations

Study Summary

The goal of this study is to validate design for the Resolve™ Stimulator and Proximity Electrode and the associated procedure to quickly and safely place an electrode into the neck, in the vicinity of the vagus nerve by a physician in either the Emergency Department or other appropriate hospital inpatient setting (e.g., ICU). The secondary goal is to confirm that the electrical signal being delivered via this electrode rapidly counters bronchoconstriction and improves airway flow.

Conditions Studied

Asthma

Interventions

  • DEVICE Resolve Stimulator and Proximity Lead

Study Locations (6)

Michigan

  • Henry Ford Health System - Detroit
  • William Beaumont Hospital - Royal Oak

Illinois

  • Rush University Medical Center - Chicago

Minnesota

  • Hennepin County Medical Center - Minneapolis

Missouri

  • Washington University School of Medicine, Barnes-Jewish Hospital, - St Louis

Texas

  • Dorrington Medical Associates - Houston

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2008-09
Est. Completion 2010-10
Phase NA

Sponsor

ElectroCore

6 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00762931

The ClinicalTrials.gov registry entry for NCT00762931 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (98% lower). The listed sponsor is ElectroCore, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Resolve Stimulator and Proximity Lead is the first listed.

NCT00762931 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Michigan, Illinois, Minnesota.

Frequently Asked Questions

What is clinical trial NCT00762931 about?

NCT00762931 is a clinical study titled "Neurostimulation for the Relief of Acute Bronchoconstriction". The goal of this study is to validate design for the Resolve™ Stimulator and Proximity Electrode and the associated procedure to quickly and safely place an electrode into the neck, in the vicinity of the vagus nerve by a physician in either the Emergency Department or other appropriate hospital inp...

What is the current status of trial NCT00762931?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2008-09. Estimated completion is 2010-10.

What conditions does trial NCT00762931 study?

This clinical trial studies the following conditions: Asthma.

What interventions are being tested in trial NCT00762931?

The interventions under investigation include: Resolve Stimulator and Proximity Lead (DEVICE).

Who is sponsoring clinical trial NCT00762931?

This trial is sponsored by ElectroCore, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00762931 being conducted?

This trial has 6 study locations across Illinois, Michigan, Minnesota, Missouri, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Asthma

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.